![Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months | FDA Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months | FDA](https://www.fda.gov/files/Booster%20Infographic_D_Rev_010622_0.png)
Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months | FDA
![COVID-19 New Booster Vaccine & Variants Update; Plus Updates on RSV, Influenza & Pneumococcal Immunizations COVID-19 New Booster Vaccine & Variants Update; Plus Updates on RSV, Influenza & Pneumococcal Immunizations](https://www.idsociety.org/globalassets/idsa/multimedia/clinician-call-slides--qa/covid-19-new-booster-vaccine--variants-update--updates-on-rsv-influenza--pneumococcal-immunizations.png)
COVID-19 New Booster Vaccine & Variants Update; Plus Updates on RSV, Influenza & Pneumococcal Immunizations
![Updated Toolkit: COVID-19 Booster Dose Messaging and Outreach Tools - Public Health Communications Collaborative (PHCC) Updated Toolkit: COVID-19 Booster Dose Messaging and Outreach Tools - Public Health Communications Collaborative (PHCC)](https://publichealthcollaborative.org/wp-content/uploads/2022/10/ENG_Twitter_updated-booster-doses-2.png)
Updated Toolkit: COVID-19 Booster Dose Messaging and Outreach Tools - Public Health Communications Collaborative (PHCC)
![DPH Shares Monthly COVID-19 Update, Announces Changes to Data Reporting and Booster Guidance - State of Delaware News DPH Shares Monthly COVID-19 Update, Announces Changes to Data Reporting and Booster Guidance - State of Delaware News](https://news.delaware.gov/files/2022/12/DPH-Shares-Monthly-COVID19-Update-Announces-Changes-to-Data-Reporting-and-Booster-Guidance-Highlights-Vaccine-Effectiveness-Study.png)
DPH Shares Monthly COVID-19 Update, Announces Changes to Data Reporting and Booster Guidance - State of Delaware News
![Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7148e1-BivalentBooster_IMAGE_22NOV2022_1200x675.jpg?_=65732)
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
![ATAGI update additional 2023 COVID-19 vaccination dose | Australian Government Department of Health and Aged Care ATAGI update additional 2023 COVID-19 vaccination dose | Australian Government Department of Health and Aged Care](https://www.health.gov.au/sites/default/files/2023-10/atagi-update-additional-2023-covid-19-vaccination-dose_1.png)